MedPath

Prevention of cardiovascular disease and progression of renal failure inpatients with chronic renal insufficiency: implementation of maximalendothelial protection with the aid of nurse practitioners. A randomizedmulti-center study.

Recruiting
Registration Number
NL-OMON25012
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
800
Inclusion Criteria

Patients are eligible for inclusion when they fulfill the following criteria:
1. The subject is at least 18 years old;
2. The subject is diagnosed with CKD with a creatinine clearance estimated by the Cockcroft-Gault equation between 20 and 70 ml/min;
3. The subject is able and willing to provide written informed consent.

Exclusion Criteria

Also none of the exclusion criteria can be present. The following conditions are considered exclusion criteria:
1. A renal transplant less than a year before inclusion;
2. Acute renal failure or rapidly progressive glomerulonephritis established by the treating physician;
3. Any malignancy less than five years before inclusion other than basocellular or squamous cell carcinoma of the skin;
4. Participation in other clinical trials requiring the use of study medication.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Assessment of cardiovascular morbidity (comprised of myocardial infarction, stroke and all vascular interventions, including amputation of an extremity due to vascular insufficiency);<br>2. Cardiovascular mortality;<br>3. All cause mortality. <br>
Secondary Outcome Measures
NameTimeMethod
1. Decline in renal function, this will be established by annual measurement of creatinine clearance by 24-hour urine measurements;<br>2. Quality of life, will be assessed using a validated questionnaire;<br>3. Markers of vascular damage: aortic pulse wave velocity, carotid intimal media thickness and the ankle-brachial index.
© Copyright 2025. All Rights Reserved by MedPath